The ahead study: effectiveness interim results after one year of observation, an analysis of the European patients cohort

被引：0
|
作者：
Oldenburg, J. [1 ]
Tsakiris, D. [2 ]
Hermans, C. [3 ]
Liesner, R. [4 ]
Mazzucconi, M. G. [5 ]
Parra, R. [6 ]
Steinitz, K. [7 ]
Abad-Franch, L. [8 ]
Loew-Baselli, A. [9 ]
机构：
[1] Bonn Univ Clin, Inst Expt Hematol & Transfus Med, Bonn, Germany
[2] Univ Basel Hosp, Diagnost Hematol, CH-4031 Basel, Switzerland
[3] St Luc Univ Hosp, Haemophilia Clin, Brussels, Belgium
[4] Great Ormond St Hosp Sick Children, Haemophilia Comprehens Care Ctr, London WC1N 3JH, England
[5] Univ Roma La Sapienza, Policlin Umberto 1, I-00185 Rome, Italy
[6] Hosp Univ Vall dHebron, Barcelona, Spain
[7] Baxter Healthcare Corp, Baxter Innovat GmbH, Vienna, Austria
[8] Baxter Healthcare SA, Zurich, Switzerland
[9] Baxter Innovat GmbH, Vienna, Austria
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO243-TUE
引用
收藏
页码：596 / 596
页数：1
相关论文
共 50 条
  • [1] The AHEAD Study: Interim Results After One Year of Observation
    Oldenburg, J.
    Tsakiris, D.
    Hermans, C.
    Khair, K.
    Mazzucconi, M. G.
    Abad-Franch, L.
    Loew-Baselli, A.
    HAEMOPHILIA, 2015, 21 : 46 - 47
  • [2] The ahead study: safety real world data after 1 year of observation, an analysis of the European cohort of patients
    Oldenburg, J.
    Tsakiris, D.
    Hermans, C.
    Liesner, R.
    Mazzucconi, M. G.
    Parra, R.
    Steinitz, K.
    Loew-Baselli, A.
    Abad-Franch, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 596 - 597
  • [3] AHEAD study update: interim results from the first year of observation
    Oldenburg, J.
    Tsakiris, D.
    Hermans, C.
    Abraham, I.
    Loew-Baselli, A.
    Pina, P.
    Spotts, G.
    Reininger, A. J.
    HAEMOPHILIA, 2014, 20 : 51 - 51
  • [4] 2nd interim analysis results of the global ahead study in hemophilia A patients
    Oldenburg, Johannes
    Tsakiris, Dimitrios
    Hermans, Cedric
    Liesner, Ri
    Mazzucconi, Maria Gabriella
    Franch, Lydia Abad
    Steinitz-Trost, Katharina
    Gringeri, Alessandro
    HAEMOPHILIA, 2016, 22 : 51 - 52
  • [5] The Ahead Study: 2nd Interim Analysis Results in 376 Patients with Haemophilia A
    Oldenburg, J.
    Tsakiris, D. A.
    Hermans, C.
    Liesner, R.
    Mazzucconi, M. G.
    Franch, L. Abad
    Steinitz-Trost, K.
    Gringeri, A.
    HAEMOPHILIA, 2016, 22 : 60 - 61
  • [6] Ranibizumab in the real world clinical setting: results from the one year interim analysis of the LUMINOUS study
    Mitchell, Paul
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [7] One year following a cohort of patients treated with rosiglitazone.: Results of the AVANTAGE study
    Slama, G
    Eschwege, E
    Bernard, MH
    Grimaldi, A
    Oppert, JM
    Pouchain, D
    Bégaud, B
    DIABETES & METABOLISM, 2006, 32 : S75 - S75
  • [8] Assessing the real-world effectiveness of ocrelizumab in patients with multiple sclerosis - confidence one-year interim analysis
    Buttmann, M.
    Meuth, S.
    Weber, M.
    Dirks, P.
    Eggebrecht, J.
    Hieke-Schulz, S.
    Leemhuis, J.
    Ziemssen, T.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 517 - 517
  • [9] ENTECAVIR EFFECTIVENESS IN NAIVE AND NUC EXPERIENCED PATIENTS: INTERIM ANALYSIS OF THE ENTAS COHORT STUDY OF PATIENTS WITH CHRONIC HEPATITIS B
    Porro, E.
    Di Leo, A.
    Marzano, A.
    Brancaccio, G.
    Maimone, S.
    Fasano, M.
    Grasso, A.
    Bronte, F.
    Fagiuoli, S.
    Santantoniol, T.
    Morisco, F.
    Petrelli, E., I
    Baroni, G. Svegliati
    Labbadia, G.
    Badia, L.
    Niro, G. A.
    Vinci, M.
    Montineri, A.
    Vinelli, F.
    Massari, M.
    Nosotti, L., I
    Galati, G.
    Missale, G.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E50 - E51
  • [10] Predictors of One-year Mortality in Older Patients With Myocardial Infarction: Results of a Cohort Study
    Saleh, Nahid
    Abasi, Farid
    Bavandpouri, Sousan Mahmoudi
    Motevaseli, Sayeh
    SALMAND-IRANIAN JOURNAL OF AGEING, 2024, 19 (03): : 470 - 483
12345